John Overdeck’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

John Overdeck’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,867	Closed	-$19.6K	–	3367
2023 Q1	$19.6K	Sell	2,867 -40	-1%	-$310	﹤0.01%	2853
2022 Q4	$20.7K	Sell	2,907 -487	-14%	-$4.64K	﹤0.01%	2677
2022 Q3	$36K	Sell	3,394 -1,142	-25%	-$14.9K	﹤0.01%	2343
2022 Q2	$59K	Sell	4,536 -4,319	-49%	-$55.6K	﹤0.01%	2331
2022 Q1	$149K	Buy	8,855 +6,117	+223%	+$113K	﹤0.01%	2381
2021 Q4	$81K	Sell	2,738 -2,993	-52%	-$122K	﹤0.01%	4096
2021 Q3	$293K	Buy	+5,731	New	+$408K	﹤0.01%	3692

Other funds holding FRLN

Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HCA

Harbor Capital Advisors Chicago, Illinois $1.47B AUM 42.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

John Overdeck's FRLN Position: Q2 2023 in Review

John Overdeck sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q2 2023, closing a stake of 2,867 shares — an estimated $19.6K sold.

John Overdeck first reported a position in FRLN in Q3 2021 and held it in 7 quarters. The position peaked at $293K in Q3 2021. 11 funds tracked by Wall St. Rank hold FRLN as of Q2 2023.

John Overdeck reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
John Overdeck sold 2,867 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q2 2023, an estimated $19.6K.
John Overdeck first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2021 and held it in 7 quarters.
John Overdeck's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $293K in Q3 2021.
11 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.